Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

NCT04462614 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hemolysis
VKA
Anticoagulants / Administration & Dosage
Coated Materials
Biocompatible
Heparin / Administration & Dosage
Membranes Artificial
Prospective Studies
Renal Dialysis / Methods
Renal Insufficiency / Therapy

Interventions

DRUG: Decrease per-dialytic heparin therapy

Sponsor

CHU de Reims